AxoGen, Inc. (NASDAQ:AXGN) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Peter Mariani - Executive Vice President and Chief Financial Officer Karen Zaderej - Chairman, President and Chief Executive Officer Conference Call Participants Jaime Morgan - SVB Leerink Brandon Folkes - Cantor Fitzgerald David Turkaly - JMP Securities Anthony Petrone - Jefferies Operator Good afternoon, ladies and gentlemen, and thank you, for standing by. Welcome to the AxoGen Incorporated First Quart ...

AxoGen, Inc. (NASDAQ:AXGN) Q3 2020 Earnings Conference Call October 29, 2020 4:30 PM ET Company Participants Pete Mariani - Chief Financial Officer Karen Zaderej - Chairman, Chief Executive Officer & President Conference Call Participants Raj Denhoy - Jefferies Chris Pasquale - Guggenheim Operator Greetings and welcome to the AxoGen Third Quarter Earnings Call. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instruct ...

Table of Contents Minnesota 41-1301878 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification No.) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.01 par value AXGN The Nasdaq Stock Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ...

Table of Contents Minnesota 41-1301878 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification No.) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.01 par value AXGN The Nasdaq Stock Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ...

AxoGen, Inc. (NASDAQ:AXGN) Q1 2020 Earnings Conference Call May 6, 2020 4:30 AM ET Company Participants Karen Zaderej - Chairman, President, and CEO Peter J. Mariani - CFO Conference Call Participants Unidentified Analyst - SVB Leerink Rajbir Denhoy - Jefferies David Turkaly - JMP Securities Unidentified Analyst - Canaccord Genuity Corp. Operator Greetings and welcome to the AxoGen First Quarter 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. A question-and- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to______________ Commission file number: 001-36046 Axogen, Inc. (Exact Name of Registrant as Specified in Its Charter) | --- | ...